United States Seventh Circuit
IN RE: BRAND NAME PRESCRIPTION DRUGS ANTITRUST LITIGATION, 00-4206, 00-4264, 00-4265, 00-4266
Read IN RE: BRAND NAME PRESCRIPTION DRUGS ANTITRUST LITIGATION, 00-4206, 00-4264, 00-4265, 00-4266
READ
READ
In an action for price-fixing under the Sherman Act, plaintiffs, retail sellers of prescription drugs, failed to adequately show that the drug manufacturers conspired to fix prices and that the drug wholesalers joined the conspiracy by adopting an alleged "chargeback" system.
Appellate Information
- Decided 05/06/2002
- Published 05/06/2002
Judges
Court
- United States Seventh Circuit